跳至主要内容
临床试验/IRCT20210724051969N1
IRCT20210724051969N1已完成3 期

Evaluation of the effect of Deuterium depleted Water (DDW) on glucose level, Insulin level, lipid profile, and parameters involved in regulation of antioxidant activity of type 2 diabetic patients

Atomic Energy Organization of Iran0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
27 years 至 77 years(—)
性别
All

入选标准

  • Patients must give their written consent to join the study voluntarily and knowingly.
  • Patients must be diagnosed with type II diabetes with HbA1c levels between 6.5 to 7.5%.
  • Patients must be under oral treatment with common medications to treat diabetes, such as sulfonyl urea, methformin, DPP4 inhibitors, SGLT2 inhibitors, pioglytazone.
  • No history of autoimmune disorders.
  • Patients must not have compromised cognitive ability.
  • Patients may not be in any stage of pregnancy or lactation.
  • Patients must be between 27-77 years of age.

排除标准

  • Lack of a knowing and voluntary patient consent in written form.
  • unwillingness to continue the study.
  • Unwillingness to adhere to the project's protocols.
  • Decision of the medical staff for any unforeseen reasons.

研究者

发起方
Atomic Energy Organization of Iran

相似试验

Evaluation of the effectiveness of Deuterium... | 临床试验